Recent Alerts
3 Contrarian stock picks, TGS, SEED, MILL ,Thursday 08-04-2011
MILL - Miller Energy exploring for oil and natural gas resources in the United States. It primarily holds interests in approximately 600,000 lease acres located in the Cook Inlet area of Alaska; and 54,500 acres of lease holdings located in the Appalachian Basin, Tennessee. Very Attractive.
SEED - Origin Agritech, an agricultural biotechnology company, specializes in the research, development and distribution of agricultural crop seeds. Its principal seed products include corn, rice, cotton, and canola. The company also involves in hybrid seed technology development. Bouncing back from 52WK Lows, Very Attractive, must be on your list.
Get Alerts that MakeMoney!® Everything else:HOTair©
2 Stocks to Watch on a Brutal Down Day, MDW, PRKR
Hot Stock Picks for Friday 07-29-2011
MDW - Midway Gold is engaged in acquisition and exploration of mineral properties in North America. Its principal properties include the Spring Valley, Midway, Pan, and Gold Rock gold and silver mineral properties located in Nevada; and the Golden Eagle gold mineral property located in Washington. Very Attractive, must be on your list.
PRKR – ParkerVision makes proprietary radio frequency (RF) products for semiconductor circuits and wireless communication products. The company offers its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. Very Attractive, keep an eye.
Get Alerts that MakeMoney!® Everything else:HOTair©
Hot Stock Picks for Thursday 07-28-2011, NEI, CTIC
NEI - Network Engines, provides application platforms and appliance solutions for original equipment manufacturers and independent software vendors worldwide. It designs and manufactures application platforms and appliance solutions on which software applications are applied for enterprise and telephony information technology networks. Very Attractive.
CTIC - Cell Therapeutics, a biopharmaceutical company is developing Pixuvri, a novel anthracycline derivative for the treatment of non-Hodgkins lymphoma, as well as for various other hematologic malignancies and solid tumors; OPAXIO, a Phase III clinical trial product for the treatment of ovarian, brain, esophageal, and non-small cell lung cancer; and Brostallicin, a phase II trial for the treatment of metastatic triple-negative breast cancer. Very Attractive, Bouncing back from 52WK Lows.
Get Alerts that MakeMoney!® Everything else:HOTair©
Don't miss this Biotech stock
Hot Stock Picks for Wednesday 07-27-2011
MYRX - Myriad Pharmaceuticals, a biotechnology company is developing small molecule drugs for the treatment of cancer. The company?s product pipeline includes clinical and pre-clinical product candidates with mechanisms of action and novel chemical structures.
Its product candidates in clinical development include Azixa (MPC-6827), which is under Phase II clinical trial for the treatment of metastatic melanoma. In addition the company has a strong pipe line of drugs under development. Very Attractive, must be on your list.
Get Alerts that MakeMoney!® Everything else:HOTair©
OTCKing
Feed Entries
